358 related articles for article (PubMed ID: 24574464)
1. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
[TBL] [Abstract][Full Text] [Related]
3. Sex is not an independent risk factor for survival in differentiated thyroid cancer.
Oyer SL; Smith VA; Lentsch EJ
Laryngoscope; 2013 Nov; 123(11):2913-9. PubMed ID: 23564257
[TBL] [Abstract][Full Text] [Related]
4. Follicular variant papillary thyroid carcinoma in a pediatric population.
Lerner J; Goldfarb M
Pediatr Blood Cancer; 2015 Nov; 62(11):1942-6. PubMed ID: 26131690
[TBL] [Abstract][Full Text] [Related]
5. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
6. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
Stratmann M; Sekulla C; Dralle H; Brauckhoff M
Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
[TBL] [Abstract][Full Text] [Related]
7. Follicular thyroid carcinoma: the role of histology and staging systems in predicting survival.
Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg; 2005 Nov; 242(5):708-15. PubMed ID: 16244545
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of a rare subtype of thyroid cancer: Spindle cell thyroid carcinoma.
Liu Z; Zhao Q; Zeng W; Wang S; Xiong Y; Guo H; Huang T; Cheng H; Guo L
Medicine (Baltimore); 2018 Nov; 97(45):e13053. PubMed ID: 30407303
[TBL] [Abstract][Full Text] [Related]
9. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
10. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
11. Eighth edition of tumor-node-metastasis staging system improve survival predictability for papillary, but not follicular thyroid carcinoma: A multicenter cohort study.
Kim M; Kim HI; Jeon MJ; Kim HK; Kim EH; Yi HS; Kim ES; Kim H; Kim BH; Kim TY; Kim SW; Kang HC; Kim WB; Chung JH; Shong YK; Kim TH; Kim WG
Oral Oncol; 2018 Dec; 87():97-103. PubMed ID: 30527251
[TBL] [Abstract][Full Text] [Related]
12. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
[TBL] [Abstract][Full Text] [Related]
13. A Bedside Risk Calculator to Preoperatively Distinguish Follicular Thyroid Carcinoma from Follicular Variant of Papillary Thyroid Carcinoma.
Englum BR; Pura J; Reed SD; Roman SA; Sosa JA; Scheri RP
World J Surg; 2015 Dec; 39(12):2928-34. PubMed ID: 26324158
[TBL] [Abstract][Full Text] [Related]
14. Differences in the Impact of Age on Mortality in Well-Differentiated Thyroid Cancer.
Yan H; Winchester DJ; Prinz RA; Wang CH; Nakazato Y; Moo-Young TA
Ann Surg Oncol; 2018 Oct; 25(11):3193-3199. PubMed ID: 30039325
[TBL] [Abstract][Full Text] [Related]
15. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
16. Threshold primary tumour sizes for nodal and distant metastases in papillary and follicular thyroid cancers.
Zaman Mu; Fatima N; Sajjad Z; Akhtar J; Islam N; Masood Q; Ahmed A
Asian Pac J Cancer Prev; 2012; 13(6):2473-6. PubMed ID: 22938406
[TBL] [Abstract][Full Text] [Related]
17. The Flip Side of NIFTP: an Increase in Rates of Unfavorable Histologic Parameters in the Remainder of Papillary Thyroid Carcinomas.
Wong KS; Strickland KC; Angell TE; Nehs MA; Alexander EK; Cibas ES; Krane JF; Howitt BE; Barletta JA
Endocr Pathol; 2017 Jun; 28(2):171-176. PubMed ID: 28271380
[TBL] [Abstract][Full Text] [Related]
18. Spinal metastases due to thyroid carcinoma: an analysis of 202 patients.
Kushchayeva YS; Kushchayev SV; Carroll NM; Felger EA; Links TP; Teytelboym OM; Bonichon F; Preul MC; Sonntag VK; Van Nostrand D; Burman KD; Boyle LM
Thyroid; 2014 Oct; 24(10):1488-500. PubMed ID: 24921429
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
